From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search

Other Names: CDG 1L; CDG1L; ALG9-CDG (CDG-IL); Congenital disorder of glycosylation, type Il ; CDG syndrome type IL; CDG-IL; Carbohydrate deficient glycoprotein syndrome type IL; Congenital disorder of glycosylation type 1L; Mannosyltransferase 7-9 deficiency; ALG9-CDG; Congenital disorder of glycosylation type IL; Carbohydrate deficient glycoprotein syndrome type 1L

A form of congenital disorders of N-linked glycosylation characterized by progressive microcephaly, hypotonia, developmental delay, drug-resistant infantile epilepsy, and hepatomegaly. Additional features that may be observed include failure to thrive, pericardial effusion, renal cysts, skeletal dysplasia, facial dysmorphism (frontal bossing, hypertelorism, depressed nasal bridge, low-seated ears, large mouth) and hydrops fetalis. The disease is caused by loss-of-function mutations in the gene ALG9 (11q23).

NIH genetic and rare disease info

ALG9-CDG (CDG-IL) is a rare disease.

Latest research - ALG9-CDG (CDG-IL)

Clinical trials


ALG9-CDG (CDG-IL) is part of WikiMD's free ^articles!

^ALG9-CDG (CDG-IL) (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available